Ichiro Kusumi, PhD, MD

  • 2Articles
  • 10KReads1
  • 2004–2022Active
  • 9Collaborators
  • 5Citations2

About

Ichiro Kusumi, PhD, MD, is affiliated with the Department of Psychiatry at Hokkaido University Graduate School of Medicine in Sapporo, Japan. Kusumi has published research on movement disorders and schizophrenia/schizoaffective disorders, including studies on metabolic changes following second-generation antipsychotic treatment and case reports on tardive dystonia management. The author's work spans from 2004 to 2022 and includes collaboration with colleagues such as Naoki Hashimoto and Norihiro Sato.

Publications

JCP
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
Original Research

Differences Among Second-Generation Antipsychotics in Effects on HbA1c

March 30, 2022

The antipsychotic blonanserin was associated with less change in glycated hemoglobin (HbA1c) levels than olanzapine, and changes in BMI were lower for both blonanserin and aripiprazole. Study results indicate...
, , , et al
JCP
Letter to the Editor

A Case of Tardive Dystonia Successfully Managed With Quetiapine

April 1, 2004

, ,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe